Page last updated: 2024-08-26

tandospirone and Depressive Disorder, Major

tandospirone has been researched along with Depressive Disorder, Major in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, J; Si, T; Su, Y; Wang, C; Wang, X; Xu, Y; Yang, F; Yu, X; Yuan, Y1
Kanba, S; Yagi, G; Yamada, K1

Trials

2 trial(s) available for tandospirone and Depressive Disorder, Major

ArticleYear
Effects of tandospirone augmentation in major depressive disorder patients with high anxiety: A multicenter, randomized, parallel-controlled, open-label study.
    Journal of psychiatric research, 2018, Volume: 99

    Topics: Adult; Anti-Anxiety Agents; Anxiety; Depressive Disorder, Major; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoindoles; Male; Middle Aged; Outcome Assessment, Health Care; Piperazines; Pyrimidines; Selective Serotonin Reuptake Inhibitors

2018
Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial.
    Psychiatry and clinical neurosciences, 2003, Volume: 57, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder, Major; Diazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoindoles; Male; Middle Aged; Personality Inventory; Piperazines; Prolactin; Pyrimidines; Serotonin Receptor Agonists; Treatment Outcome

2003